The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Regulated Diversity of Heparan Sulfate
Open accessAbstract
heparan sulfate N-acetylated N-sulfated fibroblast growth factor platelet-derived growth factor N-deacetylase/N-sulfotransferase GlcN 6-O-sulfotransferase GlcN 3-O-sulfotransferase IdoA 2-O-sulfotransferase 3′-phosphoadenosine 5′-phosphosulfate. Large numbers of proteins in animal tissues occur immobilized in the extracellular space, at cell surfaces or in the extracellular matrix. Some are anchored through interactions with other proteins. However, current research increasingly implicates proteoglycans as scaffold structures, designed to accommodate proteins through noncovalent binding to their glycosaminoglycan side chains (1Kjellén L. Lindahl U. Annu. Rev. Biochem. 1991; 60: 443-475Crossref PubMed Scopus (1660) Google Scholar). In particular, heparan sulfate (HS)1 proteoglycans are recognized as ubiquitous protein ligands. Binding of proteins to HS chains may serve a variety of functional purposes, from simple immobilization or protection against proteolytic degradation to distinct modulation of biological activity. Because of such interactions HS proteoglycans are critically involved in a variety of biological phenomena at various levels of complexity, including organogenesis in embryonic development, angiogenesis, regulation of blood coagulation and growth factor/cytokine action, cell adhesion, lipid metabolism, etc. (2Lindahl U. Lidholt K. Spillmann D. Kjellén L. Thromb. Res. 1994; 75: 1-32Abstract Full Text PDF PubMed Scopus (341) Google Scholar, 3Salmivirta M. Lidholt K. Lindahl U. FASEB J. 1996; 10: 1270-1279Crossref PubMed Scopus (392) Google Scholar, 4Rosenberg R.D. Shworak N.W. Liu J. Schwartz J.J. Zhang L. J. Clin. Invest. 1997; 99: 2062-2070Crossref PubMed Scopus (253) Google Scholar). In this review we outline the evidence for regulated expression of specific domains in HS chains and its relation to selective protein binding. Further, we consider the current information on HS biosynthesis, with the aim of understanding the mechanisms in control of generating specific saccharide sequences. Contrary to heparin, which is synthesized exclusively as serglycin proteoglycan in connective tissue-type mast cells (1Kjellén L. Lindahl U. Annu. Rev. Biochem. 1991; 60: 443-475Crossref PubMed Scopus (1660) Google Scholar), the structurally related HS is produced by most mammalian (and many other) cell types. A variety of core proteins have been shown to carry HS chains, including agrin and perlecan in the extracellular matrix (5Iozzo R.V. Matrix Biol. 1994; 14: 203-208Crossref PubMed Scopus (126) Google Scholar) and the syndecan- and glypican-type species at the cell surface (6David G. FASEB J. 1993; 7: 1023-1030Crossref PubMed Scopus (373) Google Scholar). There is so far no evidence of any correlation between the structures of core proteins and those of the attached HS chains, whereas, conversely, the fine structure of the HS chains on a given proteoglycan species may differ between cell types (7Kato M. Wang H. Bernfield M. Gallagher J.T. Turnbull J.E. J. Biol. Chem. 1994; 269: 18881-18890Abstract Full Text PDF PubMed Google Scholar). The carbohydrate backbone in heparin and HS consists of alternating hexuronic acid (d-glucuronic acid (GlcA) or l-iduronic acid (IdoA)) and d-glucosamine (GlcN) units. The GlcN residues in heparin are predominantly N-sulfated, whereas those in HS show a more varied N-substitution pattern with appreciable proportions of both N-sulfated and N-acetylated and a smaller amount of N-unsubstituted GlcN units (3Salmivirta M. Lidholt K. Lindahl U. FASEB J. 1996; 10: 1270-1279Crossref PubMed Scopus (392) Google Scholar, 8Gallagher J.T. Walker A. Biochem. J. 1985; 230: 665-674Crossref PubMed Scopus (190) Google Scholar,9van den Born J. Gunnarsson K. Bakker M.A.H. Kjellén L. Kusche-Gullberg M. Maccarana M. Berden J.H.M. Lindahl U. J. Biol. Chem. 1995; 270: 31303-31309Abstract Full Text Full Text PDF PubMed Scopus (133) Google Scholar). These structures are generated through the formation of a [GlcA-GlcNAc]n polymer that is subsequently modified by partial N-deacetylation/N-sulfation of GlcNAc units, C-5 epimerization of GlcA to IdoA residues, and, finally, incorporation of O-sulfate groups at various positions (Fig. 1). Compositional analysis of several HS preparations derived from different bovine organs revealed certain domain characteristics of unexpected regularity (10Maccarana M. Sakura Y. Tawada A. Yoshida K. Lindahl U. J. Biol. Chem. 1996; 271: 17804-17810Abstract Full Text Full Text PDF PubMed Scopus (240) Google Scholar). Thus 20–30% of the disaccharide units in all preparations were consistently arranged in alternatingN-acetylated and N-sulfated sequence (NA/NS domain in Fig. 1). Moreover, although the proportions of consecutiveN-sulfated disaccharide units (NS domain in Fig. 1) varied between preparations, those of IdoA residues within the NS domains and the extent of 2-O-sulfation of these units were remarkably constant. Very few 2-O-sulfate groups were located outside
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wnt signaling: a common theme in animal development
Cadigan, K. M., & Nusse, R. (1997) · Genes & Development · doi:10.1101/gad.11.24.3286 · Cited by 2,567
PROTEOGLYCANS: STRUCTURES AND INTERACTIONS
Kjellén, L., & Lindahl, U. (1991) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.60.070191.002303 · Cited by 1,719
Self-citationProteoglycans: Structures And Interactions
Kjellen, L. (1991) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.60.1.443 · Cited by 1,594
Heparin Structure and Interactions with Basic Fibroblast Growth Factor
Faham, S., Hileman, R. E., Fromm, J. R., Linhardt, R. J., & Rees, D. C. (1996) · Science · doi:10.1126/science.271.5252.1116 · Cited by 798
Heparin : chemical and biological properties, clinical applications
Lane, D. A., & Lindahl, U. (1989) · Edward Arnold eBooks · Cited by 533
Self-citationGuimond, S., Maccarana, M., Olwin, B. B., Lindahl, U., & Rapraeger, A. C. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80471-2 · Cited by 481
Self-citationMinimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor.
Maccarana, M., Casu, B., & Lindahl, U. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80470-0 · Cited by 454
Self-citationHeparan sulfate: a piece of information
Salmivirta, M., Lidholt, K., & Lindahl, U. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.11.8836040 · Cited by 439
Self-citationIntegral membrane heparan sulfate proteoglycans
David, G. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.11.8370471 · Cited by 418
Koenig, A., Norgard-Sumnicht, K., Linhardt, R., & Varki, A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1509 · Cited by 403
Rosenberg, R. D., Shworak, N. W., Liu, J., Schwartz, J. J., & Zhang, L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119377 · Cited by 385
More to “heparin” than anticoagulation
Lindahl, U., Lidholt, K., Spillmann, D., & Kjellén, L. (1994) · Thrombosis Research · doi:10.1016/0049-3848(94)90136-8 · Cited by 340
Self-citationLyon, M., Deakin, J. A., Mizuno, K., Nakamura, T., & Gallagher, J. T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)78113-7 · Cited by 318
Domain Structure of Heparan Sulfates from Bovine Organs
Maccarana, M., Sakura, Y., Tawada, A., Yoshida, K., & Lindahl, U. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.17804 · Cited by 284
Self-citationDefining the Interleukin-8-binding Domain of Heparan Sulfate
Spillmann, D., Witt, D., & Lindahl, U. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15487 · Cited by 273
Self-citationvan Kuppevelt, T. H., Dennissen, M. A. B. A., van Venrooij, W. J., Hoet, R. M. A., & Veerkamp, J. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.12960 · Cited by 264
Fedarko, N. S., & Conrad, H. E. (1986) · The Journal of cell biology · doi:10.1083/jcb.102.2.587 · Cited by 257
Gallagher, J. T., & Walker, A. (1985) · Biochemical Journal · doi:10.1042/bj2300665 · Cited by 252
Liver heparan sulfate structure. A novel molecular design
Lyon, M., Deakin, J. A., & Gallagher, J. T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)78112-5 · Cited by 202
Kato, M., Wang, H., Bernfield, M., Gallagher, J. T., & Turnbull, J. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32250-0 · Cited by 198
Specific Binding of the Chemokine Platelet Factor 4 to Heparan Sulfate
Stringer, S. E., & Gallagher, J. T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20508 · Cited by 198
Brickman, Y. G., Ford, M. D., Gallagher, J. T., Nurcombe, V., Bartlett, P. F., & Turnbull, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.8.4350 · Cited by 181
Kitagawa, H., Tone, Y., Tamura, J.-I., Neumann, K. W., Ogawa, T., Oka, S., Kawasaki, T., & Sugahara, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.12.6615 · Cited by 178
Shworak, N. W., Liu, J., Fritze, L. M. S., Schwartz, J. J., Zhang, L., Logeart, D., & Rosenberg, R. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.44.28008 · Cited by 163
Molecular cloning and expression of rat liver N-heparan sulfate sulfotransferase.
Hashimoto, Y., Orellana, A., Gil, G., & Hirschberg, C. B. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49598-7 · Cited by 161
Perlecan: A gem of a proteoglycan
Iozzo, R. V. (1994) · Matrix Biology · doi:10.1016/0945-053x(94)90183-x · Cited by 158
Turnbull, J. E., & Gallagher, J. T. (1991) · Biochemical Journal · doi:10.1042/bj2730553 · Cited by 154
Orellana, A., Hirschberg, C. B., Wei, Z., Swiedler, S. J., & Ishihara, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42164-8 · Cited by 149
van den Born, J., Gunnarsson, K., Bakker, M. A. H., Kjellén, L., Kusche‐Gullberg, M., Maccarana, M., Berden, J. H. M., & Lindahl, U. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.52.31303 · Cited by 149
Self-citationEriksson, I., Pikas, D. S., Ek, B., Lindahl, U., & Kjellén, L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34079-6 · Cited by 148
Self-citationAge-dependent Modulation of Heparan Sulfate Structure and Function
Feyzi, E., Saldeen, T. G. P., Larsson, E., Lindahl, U., & Salmivirta, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13395 · Cited by 144
Self-citationFeyzi, E., Trybala, E., Bergström, T. B., Lindahl, U., & Spillmann, D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.24850 · Cited by 139
Self-citationMolecular organization of the interferon γ-binding domain in heparan sulphate
Lortat‐Jacob, H., Turnbull, J. E., & Grimaud, J.-A. (1995) · Biochemical Journal · doi:10.1042/bj3100497 · Cited by 138
Feyzi, E., Lustig, F., Fager, G., Spillmann, D., Lindahl, U., & Salmivirta, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.9.5518 · Cited by 137
Self-citationJacobson, G. R., Lee, C. A., & Saier, M. H. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37905-x · Cited by 133
Molecular Cloning and Expression of Chinese Hamster Ovary Cell Heparan-sulfate 2-Sulfotransferase
Kobayashi, M., Habuchi, H., Yoneda, M., Habuchi, O., & Kimata, K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.21.13980 · Cited by 132
Jayson, G. C., Lyon, M., Paraskeva, C., Turnbull, J. E., Deakin, J. A., & Gallagher, J. T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.51 · Cited by 129
Structure of heparan sulphate from human brain, with special regard to Alzheimer's disease
Lindahl, B., Eriksson, L. G., & Lindahl, U. (1995) · Biochemical Journal · doi:10.1042/bj3060177 · Cited by 126
Self-citationTransporters of nucleotide sugars, nucleotide sulfate and ATP in the Golgi apparatus
Abeijón, C. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01053-0 · Cited by 113
Biosynthesis of heparin. Assay and properties of the microsomal uronosyl C-5 epimerase.
Bäckström, G., Höök, M., Lindahl, U., FEINGOLD, D. S., Malmström, A., Rodén, L., & Jacobsson, I. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30171-0 · Cited by 107
Self-citationGolgi retention signals: do membranes hold the key?
Machamer, C. E. (1991) · Trends in Cell Biology · doi:10.1016/0962-8924(91)90001-p · Cited by 107
Molecular Characterization and Expression of Heparan-sulfate 6-Sulfotransferase
Habuchi, H., Kobayashi, M., & Kimata, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.15.9208 · Cited by 102
Pejler, G., Danielsson, A., Björk, I., et al. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60822-1 · Cited by 101
Biosynthesis of Heparin/Heparan Sulfate
Li, J., Hagner-McWhirter, Å., Kjellén, L., Palgi, J., Jalkanen, M., & Lindahl, U. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.44.28158 · Cited by 96
Self-citationLind, T., Lindahl, U., & Lidholt, K. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36835-8 · Cited by 95
Self-citationKusche‐Gullberg, M., Eriksson, I., Pikas, D. S., & Kjellén, L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.19.11902 · Cited by 92
Self-citationParthasarathy, N., Goldberg, I. J., Sivaram, P., Mulloy, B., Flory, D. M., & Wagner, W. D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31802-1 · Cited by 90
Wei, Z., Swiedler, S. J., Ishihara, M., Orellana, A., & Hirschberg, C. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.9.3885 · Cited by 88
Amyloid-specific Heparan Sulfate from Human Liver and Spleen
Lindahl, B., & Lindahl, U. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.42.26091 · Cited by 79
Self-citationReduced Sulfation of Liver Heparan Sulfate in Experimentally Diabetic Rats
Kjellén, L., Bielefeld, D., & Hook, M. (1983) · Diabetes · doi:10.2337/diab.32.4.337 · Cited by 67
Self-citationEdge, A. S. B., & Spiro, R. G. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55480-6 · Cited by 56
Ishihara, M., Guo, Y., Wei, Z., Yang, Z., Swiedler, S. J., Orellana, A., & Hirschberg, C. B. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80698-x · Cited by 54
Cheung, W.-F., Eriksson, I., Kusche‐Gullberg, M., Lindahl, U., & Kjellén, L. (1996) · Biochemistry · doi:10.1021/bi952325b · Cited by 53
Self-citationSelective reduction of 6‐O‐sulfation in heparan sulfate from transformed mammary epithelial cells
Safaiyan, F., Lindahl, U., & Salmivirta, M. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2520576.x · Cited by 50
Self-citationvan den Born, J., Jann, K., Assmann, K. J. M., Lindahl, U., & Berden, J. H. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.37.22802 · Cited by 24
Self-citationFritz, T. A., Agrawal, P. K., Esko, J. D., & Krishna, N. R. (1997) · Glycobiology · doi:10.1093/glycob/7.5.587-c · Cited by 20
Cited by
The sequence of the human genome
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) · Science · doi:10.1126/science.1058040 · Cited by 13,909
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
Functions of Cell Surface Heparan Sulfate Proteoglycans
Bernfield, M., Götte, M., Park, P. W., Reizes, O., Fitzgerald, M. L., Lincecum, J., & Zako, M. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.729 · Cited by 2,688
The Fibroblast Growth Factor signaling pathway
Ornitz, D. M., & Itoh, N. (2015) · WIREs Developmental Biology · doi:10.1002/wdev.176 · Cited by 2,050
Order Out of Chaos: Assembly of Ligand Binding Sites in Heparan Sulfate
Esko, J. D., & Selleck, S. B. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135458 · Cited by 1,495
Metadata
- Authors
- Lindahl, U., Kusche-Gullberg, M., & Kjellén, L.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1998-09
- Volume
- 273
- Issue
- 39
- Pages
- 24979-24982
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1971540677
- Cited by
- 678
- References
- 56
- FWCI
- 14.39
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.